Company / Current Liabilities per Share
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current Liabilities per Share History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.01
FY2015
5-year range
$0.01 / $0.01
FY2011-FY2015
Trend
-51.2%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.01 to $0.01 over the past 3 years.
Based on SEC 10-K filings.
0.01 in FY2015 with a 3-year CAGR of -15.6%.
Improved from $0.01 to $0.01 over the past 3 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -15.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, current liabilities per share decreased 51.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $0.01 | -51.2% |
| FY2013 | $0.01 | +23.2% |
| FY2012 | $0.01 | +4.5% |
| FY2011 | $0.01 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026